Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078342841> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W2078342841 endingPage "365" @default.
- W2078342841 startingPage "360" @default.
- W2078342841 abstract "Results of combined treatment with low doses of steroids (50-10-5 mg) and Visken (7.5-15 mg) in 5 cases of pemphigus erythematosus and 5 cases of pemphigus vulgaris are presented. Treatment lasted from 30 days to 1.5 years. Some of the patients had been previously treated with steroids and immunosuppressive drugs, but had active lesions or frequent recurrences. In pemphigus erythematosus, very good results were obtained in 3 of 5 cases, and failure in 2 cases was probably related to insufficient dosage of steroids, or no treatment with steroids at all. In pemphigus vulgaris results were not satisfactory. Visken can serve as a supplementary drug in the treatment of pemphigus erythematosus. No complications were observed, and the drug may be regarded as safe." @default.
- W2078342841 created "2016-06-24" @default.
- W2078342841 creator A5020315658 @default.
- W2078342841 creator A5023825973 @default.
- W2078342841 creator A5050446623 @default.
- W2078342841 creator A5070447748 @default.
- W2078342841 date "1975-01-01" @default.
- W2078342841 modified "2023-10-18" @default.
- W2078342841 title "Visken as Supplementary Drug in the Treatment of Pemphigus" @default.
- W2078342841 doi "https://doi.org/10.1159/000251458" @default.
- W2078342841 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1201811" @default.
- W2078342841 hasPublicationYear "1975" @default.
- W2078342841 type Work @default.
- W2078342841 sameAs 2078342841 @default.
- W2078342841 citedByCount "2" @default.
- W2078342841 crossrefType "journal-article" @default.
- W2078342841 hasAuthorship W2078342841A5020315658 @default.
- W2078342841 hasAuthorship W2078342841A5023825973 @default.
- W2078342841 hasAuthorship W2078342841A5050446623 @default.
- W2078342841 hasAuthorship W2078342841A5070447748 @default.
- W2078342841 hasConcept C126322002 @default.
- W2078342841 hasConcept C16005928 @default.
- W2078342841 hasConcept C2780035454 @default.
- W2078342841 hasConcept C2781313415 @default.
- W2078342841 hasConcept C2781327288 @default.
- W2078342841 hasConcept C2986900798 @default.
- W2078342841 hasConcept C71924100 @default.
- W2078342841 hasConcept C98274493 @default.
- W2078342841 hasConceptScore W2078342841C126322002 @default.
- W2078342841 hasConceptScore W2078342841C16005928 @default.
- W2078342841 hasConceptScore W2078342841C2780035454 @default.
- W2078342841 hasConceptScore W2078342841C2781313415 @default.
- W2078342841 hasConceptScore W2078342841C2781327288 @default.
- W2078342841 hasConceptScore W2078342841C2986900798 @default.
- W2078342841 hasConceptScore W2078342841C71924100 @default.
- W2078342841 hasConceptScore W2078342841C98274493 @default.
- W2078342841 hasIssue "6" @default.
- W2078342841 hasLocation W20783428411 @default.
- W2078342841 hasLocation W20783428412 @default.
- W2078342841 hasOpenAccess W2078342841 @default.
- W2078342841 hasPrimaryLocation W20783428411 @default.
- W2078342841 hasRelatedWork W1554377917 @default.
- W2078342841 hasRelatedWork W1983681111 @default.
- W2078342841 hasRelatedWork W2078342841 @default.
- W2078342841 hasRelatedWork W2398216003 @default.
- W2078342841 hasRelatedWork W2416799531 @default.
- W2078342841 hasRelatedWork W2947466769 @default.
- W2078342841 hasRelatedWork W4200324425 @default.
- W2078342841 hasRelatedWork W4320491243 @default.
- W2078342841 hasRelatedWork W2549144158 @default.
- W2078342841 hasRelatedWork W3121915352 @default.
- W2078342841 hasVolume "150" @default.
- W2078342841 isParatext "false" @default.
- W2078342841 isRetracted "false" @default.
- W2078342841 magId "2078342841" @default.
- W2078342841 workType "article" @default.